Cardiovascular Primary Prevention Research Center
| About the Center |
The Cardiovascular Primary Prevention Research Center, affiliated with Tehran Heart Center and Tehran University of Medical Sciences, was established in 2016 to advance research and practice in the primary prevention of cardiovascular disease. As one of Iran’s first dedicated research center in this field, its mission is to identify cardiovascular risk factors within the Iranian population, develop evidence-based screening and preventive interventions, and translate research findings into clinical practice, public health programs, and national health policy.
The Center conducts basic, clinical, epidemiological, and community-based research on atherosclerotic cardiovascular disease, arrhythmias, cardiomyopathies, and modifiable cardiometabolic risk factors. It also supports cardiovascular screening, health-literacy initiatives, professional education, researcher training, and knowledge translation for the public.
Its principal strengths include its multidisciplinary expertise, integration within a major tertiary cardiovascular hospital, access to extensive clinical registries and diverse patient populations, and strong national and international collaborations. The Center is particularly distinguished by its emphasis on applied, population-oriented, and product-driven research, including digital cardiovascular health tools, community prevention programs, risk prediction, and innovative preventive technologies.
| Research Focus Area |
- Cardiovascular Disease Primary Prevention
- Cardiovascular Risk Assessment and Screening
- Cardiovascular Epidemiology
- Cardiometabolic Risk Factors
- Lifestyle and Behavioral Interventions
- Community-Based Cardiovascular Prevention
- Preventive Cardiology and Health Promotion
| Expertise, Facilities & Research Services |
- Clinical, Epidemiological, and Interventional Research – Expertise in cohort studies, cross-sectional studies, clinical trials, community-based interventions, systematic reviews, cardiovascular outcomes research, and preventive cardiology.
- Integrated Databases, Registries, and Research Analytics – Access to Tehran Heart Center clinical databases, cardiovascular registries, and population-based datasets, including the Tehran Cohort Study, supported by expertise in biostatistics, epidemiological modelling, cardiovascular risk prediction, and health-services research.
- Advanced Cardiovascular Diagnostics and Imaging – Access to the facilities of a specialized tertiary cardiovascular center, including cardiovascular magnetic resonance imaging, computed tomography angiography, echocardiography, coronary angiography and catheterization laboratories, Holter monitoring, electrophysiological assessment, and tilt-table testing.
- Cardiac Surgery, Critical Care, and Rehabilitation Facilities – Access to cardiac surgery operating rooms and wards, cardiovascular intensive care units, perioperative services, and comprehensive cardiac rehabilitation facilities for surgical, postoperative, exercise-based, and secondary-prevention research.
- Laboratory and Multidisciplinary Research Support – Access to the hospital’s clinical laboratory services for biochemical, hematological, metabolic, and cardiovascular biomarker assessment, together with multidisciplinary expertise in cardiology, endocrinology, nutrition, exercise medicine, genetics, health psychology, epidemiology, and health promotion.
- Research Development and Knowledge Translation – Support for study design, protocol development, data analysis, scientific writing, guideline development, digital health research, investigator training, and translation of cardiovascular evidence into clinical practice and public-health education.
| Collaboration Opportunities |
The Center welcomes national and international collaborations that advance cardiovascular disease prevention through multidisciplinary and translational research. Priority opportunities include joint epidemiological, clinical, and community-based studies; multicenter clinical trials; collaborative use of hospital registries, cohort datasets, and specialized cardiovascular facilities; and development of risk-prediction tools, digital health platforms, medical devices, and preventive technologies.
| Director & Key Researchers |
Director:
- Ali Vasheghani-Farahani, MD
Deputy Director for Research:
- Haleh Ashraf, MD
Principal Faculty Members and Research Council:
- Maryam Abolhasani, MD
- Pouria Ahmadi, MD
- Farshid Alaeddini, MD
- Elham Alipour, MD
- Mohsen Ghadami, MD
- Motahareh Hatami, MD
- Kaveh Hosseini, MD
- Mohammad Javad Hosseinzadeh-Attar, MD
- Arash Jalali, MD
- Farzad Masoudkabir, MD
- Ali Pasha Meysamie, MD
- Hossein Rezaeizadeh, MD
- Akbar Shafiee, MD
Research Team
- Negar Ebrahimi, MD
- Parisa Firouzbaksh, MD
- Muhammadhosein Moradi, MD
| Selected Achievements |
Development of the transcutaneous auricular vagus nerve stimulation (TaVNS) Device
- Design and prototype development of a transcutaneous auricular vagus nerve stimulation device for non-invasive cardiovascular neuromodulation, with pilot research focused on postoperative atrial fibrillation.
Development of the GhalbMa Digital Health Platform
- Development of a cardiovascular prevention platform providing risk-factor screening, cardiovascular risk assessment, lifestyle evaluation, personalized recommendations, referral management, and follow-up.
Establishment of the Saraye Salamat Health Education Platform
- Development of an online scientific and public-health platform that delivers evidence-based information on cardiovascular diseases, risk factors, and preventive strategies in accessible language for the general public.
High-Impact Scientific Publications
- The Center has produced 333 scientific publications, including 118 international collaborative articles, with 4,958 citations over the previous five years and an H-index of 31. A notable example is the highly cited Q1 review, “Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention,” published in Atherosclerosis in 2017 and cited approximately 150 times.
Contribution to National Cardiovascular Clinical Guidelines
- The Center contributed to the development of national clinical guidelines for hypertension and acute coronary syndrome, supporting the translation of research evidence into standardized cardiovascular prevention and clinical practice.
| Why Collaborate with Us? |
The Center offers access to large and diverse cardiovascular patient populations, hospital-based registries, clinical databases, and population-based cohorts within a specialized tertiary cardiovascular center. Its multidisciplinary team integrates cardiology, epidemiology, biostatistics, nutrition, behavioral science, and health promotion. Strong translational capacity enables progression from risk-factor research and predictive modelling to clinical trials, digital health platforms, medical-device development, and public-health implementation. Established national and international collaborations, combined with advanced diagnostic, interventional, surgical, rehabilitation, and laboratory infrastructure, provide a robust environment for high-impact cardiovascular prevention research.
| Contact Information |
Official Name: Cardiac Primary Prevention Research Center
Affiliation: Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
Postal Address: Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran Heart Center Hospital, North Kargar Avenue, Tehran, Iran
Telephone: +98 21 8802 9729
Email: cpprc.thc@gmail.com
Website: www.cpprc.tums.ac.ir
